Formed in 2018 by Equitix and Helios Energy Investments, Bio Capital owns and operates AD plants in the UK with a growing and diverse portfolio. We invest in both operational and greenfield assets, comprising of gas-to-grid, vehicle fuel and electricity generation. The group currently can generate 34MW annually with a combined yearly capacity of 520,000 tonnes for treatment of food waste and 80,000 tonnes for Agri-feedstock, making us one of the largest AD operators in the UK. Our purpose is for our AD expertise to make a real contribution to the UK’s transition to Net Zero and also have a positive impact on nature. We aim to lead the market with high performing assets working to the best industry standards, delivering organic wastes diverted from landfill and products that reduce the carbon impacts of the transport sector, the gas grid and the fertiliser industry. As a Group, we have a clear vision of responsible growth to achieve our purpose and, through innovative practices, continue to work towards a stronger circular economy.
| Website | http://www.bio-capital.co.uk |
| Employees | 53 (53 on RocketReach) |
| Founded | 2018 |
| Industry | Biotechnology |
| Keywords | Renewable Energy Investment, Sustainable Energy, Clean Energy Solutions, Renewable Energy Assets, Energy Infrastructure, Waste To Energy, Anaerobic Digestion, Green Energy Projects, Bioenergy, Biogas Production, Biomass Energy, Greenfield Investment, Alternative Fuels, Vehicle Fuel |
| Competitors | Thermo Fisher Scientific, AstraZeneca, Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Biogen, CureVac, Gamma Biosciences +42 more (view full list) |
Looking for a particular Bio Capital employee's phone or email?
James McQuaid is the CFO of Bio Capital.
53 people are employed at Bio Capital.